Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 13,858,000 | 12,902,000 | 10,425,000 | 8,619,000 | 8,704,000 |
| Cost of Goods | 4,684,000 | 5,050,000 | 3,711,000 | 1,942,000 | 2,006,000 |
| Gross Profit | 9,174,000 | 7,852,000 | 6,714,000 | 6,677,000 | 6,698,000 |
| Operating Expenses | 5,421,000 | 4,597,000 | 5,962,000 | 3,074,000 | 2,742,000 |
| Operating Income | 3,753,000 | 3,255,000 | 752,000 | 3,603,000 | 3,956,000 |
| Interest Expense | 629,000 | 630,000 | 632,000 | 563,000 | 559,000 |
| Other Income | -4,631,000 | -125,000 | -813,000 | 58,000 | -323,000 |
| Pre-tax Income | -1,507,000 | 2,500,000 | -693,000 | 3,098,000 | 3,074,000 |
| Income Tax | -1,545,000 | 187,000 | 46,000 | 88,000 | 273,000 |
| Net Income Continuous | 38,000 | 2,313,000 | -739,000 | 3,010,000 | 2,801,000 |
| Minority Interests | -2,000 | -5,000 | 1,000 | N/A | N/A |
| Net Income | $36,000 | $2,308,000 | $-738,000 | $3,010,000 | $2,801,000 |
| EPS Basic Total Ops | 0.00 | 0.14 | -0.05 | 0.21 | 0.20 |
| EPS Basic Continuous Ops | 0.00 | 0.14 | -0.05 | 0.21 | 0.20 |
| EPS Diluted Total Ops | 0.00 | 0.14 | -0.05 | 0.21 | 0.20 |
| EPS Diluted Continuous Ops | 0.00 | 0.14 | -0.05 | 0.21 | 0.20 |
| EBITDA(a) | $1,187,000 | $5,422,000 | $1,494,000 | $4,220,000 | $4,142,000 |